Skip to main content

Table 3 Stratification analysis of APOC3 3238 C/G polymorphisms in coronary artery disease cases

From: Apolipoprotein C3 genetic polymorphisms are associated with lipids and coronary artery disease in a Chinese population

  Cases CC CG GG
n (%) OR (95% CI) P n (%) OR (95% CI) P n (%) OR (95% CI) P
Smoking status 600 414(69.0) 1(Reference)   114(19.0) 1(Reference)   72(12.0) 1(Reference)  
 Ever 192 133(69.3) 1.00(0.78,1.29) 0.98 35(18.2) 0.96(0.64,1.45) 0.84 24(12.5) 1.04(0.64,1.70) 0.87
 Never 408 281(68.9) 0.99(0.82,1.22) 0.99 79(19.4) 1.02(0.75,1.39) 0.91 48(11.7) 0.98(0.67,1.44) 0.92
Diabetes 600 414(69.0) 1(Reference)   114(19.0) 1(Reference)   72(12.0) 1(Reference)  
 Positive 156 107(68.6) 0.99(0.75,1.31) 0.97 30(19.2) 1.01(0.65,1.57) 0.96 19(12.2) 1.02(0.59,1.73) 0.96
 Negative 444 307(69.1) 1.00(0.83,1.21) 0.98 84(18.9) 1.00(0.73,1.35) 0.98 53(11.9) 0.99(0.68,1.45) 0.98
Obesity 600 414(69.0) 1(Reference)   114(19.0) 1(Reference)   72(12.0) 1(Reference)  
 Positive 176 120(68.2) 0.99(0.76,1.29) 0.93 35(19.9) 1.05(0.69,1.58) 0.83 21(11.9) 0.99(0.60,1.66) 0.98
 Negative 424 294(69.3) 1.01(0.83,1.22) 0.96 79(18.6) 0.98(0.72,1.34) 0.90 51(12.0) 1.00(0.69,1.47) 0.99
Hyperlipidemia 600 414(69.0) 1(Reference)   114(19.0) 1(Reference)   72(12.0) 1(Reference)  
 Positive 188 117(62.2) 0.90(0.69,1.17) 0.44 32(17.0) 0.90(0.59,1.37) 0.61 39(20.7) 1.73(1.13,2.64) 0.01
 Negative 412 297(72.1) 1.05(0.86,1.27) 0.66 82(19.9) 1.05(0.77,1.43) 0.77 33(8.0) 0.67(0.43,1.03) 0.07